Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1963 2
1965 3
1966 3
1967 1
1968 4
1969 3
1970 8
1971 1
1972 3
1973 4
1974 6
1975 9
1976 13
1977 6
1978 8
1979 3
1980 8
1981 9
1982 16
1983 9
1984 19
1985 21
1986 26
1987 26
1988 30
1989 27
1990 48
1991 38
1992 47
1993 47
1994 84
1995 74
1996 94
1997 113
1998 119
1999 130
2000 153
2001 201
2002 225
2003 215
2004 296
2005 348
2006 388
2007 440
2008 492
2009 569
2010 653
2011 736
2012 791
2013 898
2014 945
2015 1140
2016 1153
2017 1217
2018 1324
2019 1483
2020 1751
2021 1988
2022 2161
2023 2194
2024 404

Text availability

Article attribute

Article type

Publication date

Search Results

20,693 results

Results by year

Filters applied: . Clear all
Page 1
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.
Shang P, Rong N, Jiang JJ, Cheng J, Zhang MH, Kang D, Qi L, Guo L, Yang GM, Liu Q, Zhou Z, Li XB, Zhu KK, Meng QB, Han X, Yan W, Kong Y, Yang L, Wang X, Lei D, Feng X, Liu X, Yu X, Wang Y, Li Q, Shao ZH, Yang F, Sun JP. Shang P, et al. Among authors: cheng j. Cell. 2023 Nov 22;186(24):5347-5362.e24. doi: 10.1016/j.cell.2023.10.014. Epub 2023 Nov 13. Cell. 2023. PMID: 37963465
Intravascular Large B-Cell Lymphoma.
Cheng JW, Li JH. Cheng JW, et al. N Engl J Med. 2023 Dec 7;389(23):2188. doi: 10.1056/NEJMicm2307122. N Engl J Med. 2023. PMID: 38055255 No abstract available.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: cheng j. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
SARS-CoV-2 immunity in animal models.
Chen Z, Yuan Y, Hu Q, Zhu A, Chen F, Li S, Guan X, Lv C, Tang T, He Y, Cheng J, Zheng J, Hu X, Zhao J, Zhao J, Sun J. Chen Z, et al. Among authors: cheng j. Cell Mol Immunol. 2024 Feb;21(2):119-133. doi: 10.1038/s41423-023-01122-w. Epub 2024 Jan 18. Cell Mol Immunol. 2024. PMID: 38238440 Free PMC article. Review.
Gene Regulatory Networks in Coronary Artery Disease.
Cheng J, Cheng M, Lusis AJ, Yang X. Cheng J, et al. Curr Atheroscler Rep. 2023 Dec;25(12):1013-1023. doi: 10.1007/s11883-023-01170-7. Epub 2023 Nov 27. Curr Atheroscler Rep. 2023. PMID: 38008808 Review.
Bond-selective full-field optical coherence tomography.
Zong H, Yurdakul C, Zhao J, Wang Z, Chen F, Ünlü MS, Cheng JX. Zong H, et al. Among authors: cheng jx. Opt Express. 2023 Dec 4;31(25):41202-41218. doi: 10.1364/OE.503861. Opt Express. 2023. PMID: 38087525 Free article.
Acinetobacter baumannii: an evolving and cunning opponent.
Shi J, Cheng J, Liu S, Zhu Y, Zhu M. Shi J, et al. Among authors: cheng j. Front Microbiol. 2024 Jan 22;15:1332108. doi: 10.3389/fmicb.2024.1332108. eCollection 2024. Front Microbiol. 2024. PMID: 38318341 Free PMC article. Review.
20,693 results
You have reached the last available page of results. Please see the User Guide for more information.